<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://www.mynewsdesk.com/se/rss/source/6349/image"/>
    <title>Takeda Pharma AB - bilder</title>
    <link>https://www.mynewsdesk.com/se/takeda/images</link>
    <description>Mynewsdesk nyhetsfeed direkt från källan</description>
    <image>
      <title>Takeda Pharma AB - bilder</title>
      <link>https://www.mynewsdesk.com/se/takeda/images</link>
      <url>https://www.mynewsdesk.com/assets/graphics/logos/logo-small-3b24ab90.png</url>
      <width>128</width>
      <height>23</height>
    </image>
    <language>sv</language>
    <ttl>15</ttl>
<item>
  <title>saija-riitta-silvola-1-color-gray-bg (002).jpg</title>
  <pubDate>Thu, 22 Jan 2026 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/saija-riitta-silvola-1-color-gray-bg-002-punkt-jpg-3399235"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/uz80l9mgotkazyzf8lgugc" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/saija-riitta-silvola-1-color-gray-bg-002-punkt-jpg-3399235?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/saija-riitta-silvola-1-color-gray-bg-002-punkt-jpg-3399235?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>ADHDivardagen_podcast_avsnittsbild_1x13.png</title>
  <pubDate>Fri, 11 Apr 2025 11:49:27 +0200</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x13-punkt-png-3230663"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/s9dy5o8p0g8vf584a5gkmv" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x13-punkt-png-3230663?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x13-punkt-png-3230663?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>ADHDivardagen_podcast_avsnittsbild_1x14.png</title>
  <pubDate>Fri, 11 Apr 2025 11:49:27 +0200</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x14-punkt-png-3230662"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/py23dx3on0525u871yrago" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x14-punkt-png-3230662?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x14-punkt-png-3230662?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>ADHDivardagen_podcast_avsnittsbild_1x12.png</title>
  <pubDate>Fri, 11 Apr 2025 11:49:27 +0200</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x12-punkt-png-3230661"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/3kdbyczr5w5d8srqo9niho" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x12-punkt-png-3230661?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x12-punkt-png-3230661?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>ADHDivardagen_podcast_avsnittsbild_1x15.png</title>
  <pubDate>Fri, 11 Apr 2025 11:49:27 +0200</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x15-punkt-png-3230660"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/vat1umgogts3w17fsqaxw8" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x15-punkt-png-3230660?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/adhdivardagen-podcast-avsnittsbild-1x15-punkt-png-3230660?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Philip Lindner Fotograf Ahang Bashi.jpg</title>
  <pubDate>Fri, 14 Mar 2025 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/philip-lindner-fotograf-ahang-bashi-punkt-jpg-3208690"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/a7fjnc9jhwlgq47wot6wtg" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/philip-lindner-fotograf-ahang-bashi-punkt-jpg-3208690?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/philip-lindner-fotograf-ahang-bashi-punkt-jpg-3208690?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>screen-24@2x-wbg.png</title>
  <pubDate>Fri, 14 Mar 2025 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/screen-24-snabel-a-2x-wbg-punkt-png-3208674"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/v0natihdgn1ihp289gx19q" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/screen-24-snabel-a-2x-wbg-punkt-png-3208674?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/screen-24-snabel-a-2x-wbg-punkt-png-3208674?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>screen-28@2x-wbg.png</title>
  <pubDate>Fri, 14 Mar 2025 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/screen-28-snabel-a-2x-wbg-punkt-png-3208673"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/89y02t4a4ak6i5sl0x3zed" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/screen-28-snabel-a-2x-wbg-punkt-png-3208673?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/screen-28-snabel-a-2x-wbg-punkt-png-3208673?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>young-woman-holding-mobile.jpg</title>
  <pubDate>Fri, 14 Mar 2025 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/young-woman-holding-mobile-punkt-jpg-3208663"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/u5ekbk1ewjz5u1sd0fnnkq" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/young-woman-holding-mobile-punkt-jpg-3208663?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/young-woman-holding-mobile-punkt-jpg-3208663?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Takeda fywy.png</title>
  <pubDate>Fri, 14 Mar 2025 09:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/takeda-fywy-punkt-png-3208655"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/ngsnmnp307qljxnbv7bnk4" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/takeda-fywy-punkt-png-3208655?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/takeda-fywy-punkt-png-3208655?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Roland close.jpg</title>
  <pubDate>Tue, 04 Mar 2025 14:00:00 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/roland-close-punkt-jpg-3203799"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/cumqmxxb3sct644q3g95sg" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/roland-close-punkt-jpg-3203799?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/roland-close-punkt-jpg-3203799?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Annika Alterius June 2024 (002).jpg</title>
  <pubDate>Mon, 30 Sep 2024 12:30:50 +0200</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/annika-alterius-june-2024-002-punkt-jpg-3107610"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/9dym024oefcjtgjracopso" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/annika-alterius-june-2024-002-punkt-jpg-3107610?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/annika-alterius-june-2024-002-punkt-jpg-3107610?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Ovanligt.se</title>
  <pubDate>Thu, 29 Feb 2024 09:51:39 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-2974185"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/iaatqw8dj28ajddukm6q" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-2974185?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-2974185?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Per Rydingsvärd, Business Unit Director Rare Diseases Takeda</title>
  <pubDate>Thu, 29 Feb 2024 09:51:39 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974184"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/jqc3uboj65nuqmgvh9tg" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974184?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974184?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Anna forsberg TT</title>
  <pubDate>Thu, 29 Feb 2024 09:51:39 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974182"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/fual3flujc19htiaftho" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974182?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974182?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Vatro Mateljic, VD Takeda Sverige</title>
  <pubDate>Thu, 29 Feb 2024 09:51:39 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/vatro-mateljic-vd-takeda-sverige-2974181"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/somm4kchyyse5lmalow8" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/vatro-mateljic-vd-takeda-sverige-2974181?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/vatro-mateljic-vd-takeda-sverige-2974181?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Ovanligt.se logo</title>
  <pubDate>Thu, 29 Feb 2024 09:51:39 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974180"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/iz6f3mnveifs58kygxfv" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974180?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974180?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Ovanligt.se logo</title>
  <pubDate>Thu, 29 Feb 2024 09:43:03 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974168"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/hlhbm7u0zcrl7lazaiil" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974168?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/ovanligt-punkt-se-logo-2974168?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Anna forsberg TT</title>
  <pubDate>Thu, 29 Feb 2024 09:43:03 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974167"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/jjs9jbimbmqhctfkpf6f" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974167?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/anna-forsberg-tt-2974167?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
<item>
  <title>Per Rydingsvärd, Business Unit Director Rare Diseases Takeda</title>
  <pubDate>Thu, 29 Feb 2024 09:43:03 +0100</pubDate>
  <description>
        &lt;a href="https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974166"&gt;&lt;img src="https://mnd-assets.mynewsdesk.com/image/upload/c_fill,dpr_auto,f_auto,g_auto,h_250,q_auto:good,w_250/bs7cukvsypsspzqqvk8f" /&gt;&lt;/a&gt;
        &lt;p&gt;&lt;/p&gt;
      </description>
  <guid>https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974166?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>https://www.mynewsdesk.com/se/takeda/images/per-rydingsvaerd-business-unit-director-rare-diseases-takeda-2974166?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Takeda Pharma AB</dc:creator>
</item>
  </channel>
</rss>
